PMDA drug package insert
アドリアシン注用10
PMDA Prescription drug · サンドファーマ株式会社 · package insert Nov 24, 2022
Key facts
| Brand names | アドリアシン注用10, アドリアシン注用50 |
|---|---|
| Nonproprietary names | ドキソルビシン塩酸塩 |
| Companies | 製造販売／サンドファーマ株式会社, 販売／サンド株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤 |
| Therapeutic category codes | 874235 |
| YJ codes | 4235402D1030, 4235402D2036 |
| Approval numbers | 21800AMX10312, 22200AMX00787 |
| Package insert edition | 第1版 |
| Package insert date | Nov 24, 2022 |
| PMDA document key | 112268_4235402D1030_2 |
| PMDA company code | 112268 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: